The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Ketamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

It is a hallucinogenic drug, and is a controlled substance designed for use as an aesthetics. It also has now been touted for ...

Those who said they used other drugs were likelier to report ketamine use as well, Yang says. Participants with depression were likelier to report ketamine use than those without depression ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...